Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung Cancer, Breast Cancer, Colon Cancer, or Pancreatic Cancer

NCT00034827 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00034827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00034827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung Cancer, Breast Cancer, Colon Cancer, or Pancreatic Cancer
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2002
Completion date
May 31, 2003
Enrollment
172
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, carcinoma, non-small-cell lung, colorectal neoplasms, pancreatic neoplasms